Washington (SmartAboutHealth) - According to a new study, the diabetes drug Avandia poses higher risks of both death and heart failure compared to the rival drug Actos..

The GlaxoSmithKline drug Avandia has been under a lot of controversy as of late due to safety issues.

A new study was led by Dr. Wolfgang Winkelmayer of the Brigham and Women’s Hospital in Boston has found that the risk of death and heart failure was higher for patients taking Avandia compared to Actos from Takeda Pharmaceuticals.

The study featured a head-to-head comparison of thw two drugs.

They found no difference, however, in the risk of heart attack and stroke.

The study was published in the Archives of Internal Medicine.